https://bswhealth.webex.com/bswhealth/j.php?MTID=m55f7d1c49a1766fb20a761a41587a0ff

OBJECTIVES: Upon completion of this activity, the participant should be able to:
1. Review contemporary lipid-management guidelines, including current low-density lipoprotein cholesterol (LDL-C) thresholds and treatment goals across risk categories.
2. Discuss emerging lipid-lowering therapies, including oral PCSK9 inhibitors, cholesteryl ester transfer protein (CETP) inhibitors, lipoprotein(a) [Lp(a)]-targeted agents, angiopoietin-like protein 3 (ANGPTL3) and apolipoprotein C-lll (ApoC-III) inhibitors, and gene-editing approaches, and review pivotal and ongoing clinical trials.
3. Identify practical considerations in lipid management, including safety monitoring, statin intolerance, treatment intensification, and barriers to achieving guideline-recommended LDL-C targets.

FACULTY DISCLOSURE: Shahzeb Khan, MD, MSc, is a consultant for Bayer, Novartis, Boehringer Ingelheim, and is a researcher for Merck.

PLANNER DISCLOSURE: The planners have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Javed Butler, MD is a consultant for Abbott, Adaptyx, American Regent, Amgen, AskBio, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cardiac Dimension, Cardior, CSL Vifor, CVRx, Cytokinetics, Daxor, Diastol, Edwards, Element Sciences, Faraday, Idorsia, Impulse Dynamics, Imbria, Innolife, Intellia, Inventiva, Levator, Lexicon, Eli Lilly, Mankind, Medtronic, Merck, New Amsterdam, Novartis, Pfizer, Pharmacosmos, Pharmain, Prolaio, Pulnovo, Regeneron, Renibus, Reprieve, Roche, Rycarma, Saillent, Salamandra, Salubris, SC Pharma, SQ Innovation, Secretome, Sequanna, Transmural, TekkunLev, Tenex, Tricog, Ultromic, Vera, Zoll.

Javed Butler, MD was a consultant for Applied Therapeutic, Astellas, CSL Bearing, Foundry, Impulse Dynamics, Imbria, Ionis, Lilly, LivaNova, Janssen, Occlutech, Owkin, Sanofi, Vifor.

CONTENT REVIEWER DISCLOSURE: Alaina Tellson PhD, RN, NPD-BC, NE-BC; and Crystal Brooks, LCSW, ACM-SW, CTP have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES: Baylor Scott & White Health is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

 

Session date: 
12/17/2025 - 12:00pm to 1:00pm CST
Location: 
WebEx
Dallas, TX
United States
  • 1.00 AMA PRA Category 1 Credit
    The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 ANCC
    Baylor Scott & White Health is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
  • 1.00 Attendance
Please login or register for this course.